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VARIABLE SURVIVAL DEATH TOTAL
Source of stem cell
Related BM/PBSC 32 10 37
Unrelated PBSC 10 12 22
Unrelated cord 4 4 8
HLA match
Matched 28 14 42
Haplo-identical 23 12 25
Conditioning
Regimen
Myelo-ablative 22 13 35
Non-myeloablative 19 13 32
Use of TBI 9 9 18
Underlying disease
Non-malignant 32 17 49
Malignant 9 9 18
Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33S24any similar units in the public sector. And of course, the key to success of
any HSCT Centre is good team work. We hope more such units are
developed with a similar public private partnership, so that no child in
need of HSCT is turned away for want of funds.
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Background: Regimen related toxicities form the major causes of trans-
plant related morbidity and mortality and have a major impact on the
outcome in children undergoing haematopoietic stem cell transplantation
(HSCT). Severe toxicity involving one organ or involvement of multiple
organs predicts a poor response. There is limited data from our country on
treatment outcomes of children undergoing HSCT requiring intensive care
support. In view of the high cost of supportive care, we aimed to analyse
the impact of aggressive paediatric intensive care unit (PICU) support in
these children.
Patients and methods: Data on all the PICU admissions among children
<18 years of age who underwent HSCT over 3 years from August 2013 to
August 2016 at Apollo Speciality hospital, Chennai was collected
by retrospective analysis of the hospital records including case ﬁles
and discharge or death summaries of patients. The risk factors analysed
wereTYPE OF DISEASE BENIGN VERSUS MALIGNANT
SOURCE OF GRAFT RELATED VERSUS UNRELATED
GRAFT VERSUS HOST
DISEASE - GVHD
PRESENT OR ABSENT
REASON FOR ADMISSION SEPSIS, CNS, GASTROINTESTINAL,
LIVER, RENAL, COAGULOPATHY
ĂResults: Of the total 238paediatric transplants during the studyduration, 72
children (30%) required PICU admission at a mean post infusion day of D+5.
About 30% of the children had been transplanted for malignancies and 70%
were benign with primary immune deﬁciency disorders requiring
maximumPICUcare. Sibling graftwasused in59% andunrelated graft in 41%
of children. One-third of children had acute GVHD at the time of admission.
The most common indication for PICU care was septic shock with 48% of
children. Seizures contributed to 22% and respiratory distress in 23.3%. Of
the children who had sepsis, the gastrointestinal tract was the focus in
29.7% and lungs in 43%. The incidence of various organ dysfunctions in our
cohort of patients included 73% hepatic involvement, 67% renal dysfunc-
tion, 56% gut involvement, 44% with coagulopathy and 43% CNS involve-
ment. When the mortality data was analysed, there was a trend towards
higher mortality in the PID group as these children had previously been
treated in intensive care units for various infections with multiple anti-
biotics. The mortality was higher in unrelated at 50% as compared to sib-
ling graft at 27%.The presence of graft versus host disease did not have an
effect on outcome. Sepsis with liver or renal dysfunction carried a high
mortality.
Conclusions: The overall mortality was 40% with bacterial sepsis with
septic shock and multi-organ dysfunction syndrome being the most
common cause of early transplant relatedmortality. The presence of one or
more organ dysfunction, especially hepatic or renal, was a predictor of
poor outcome. The mortality rates were higher in unrelated or mis-
matched grafts. However, about 60% of the children could be salvagedwith
PICU support and all children undergoing HSCT must be cared for in har-
mony with the PICU team.SCT-1_V1.7
TURNINGWEAKNESS TO STRENGTH e LESSONS LEARNT IN DELIVERING
CURE FOR PRIMARY IMMUNE DEFICIENCY DISORDERS
Ramya Uppuluri, S. Divya, J. Dhaarani, V.S. Venkateswaran, V.
Lakshmanan, Revathi Raj. Department of Paediatric Haematology,
Oncology and Blood and Marrow Transplantation, Apollo Speciality
Hospital, Chennai, India
Aim: Haematopoietic stem cell transplantation (HSCT) is the only form of
cure in children with primary immune deﬁciency disorders (PID). There is
very little data to ﬁnd predictors of morbidity and mortality from our
country. We aimed to analyse information could translate into early
